New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 6, 2014
07:41 EDTTSROTESARO price target lowered to $43 from $57 at RW Baird
Baird lowered its price target on TESARO citing the potential for a significant new competitor for one of its key drugs. The firm believes its Rolapitant P3 commercial thesis remains intact but worry the its competitor's formulation may be closer to reality than previously thought. Shares remain Outperform rated but cautious.
News For TSRO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 20, 2014
07:04 EDTTSRORoche approval would be positive for TESARO, says Jefferies
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use